Avalo Therapeutics (AVTX) Insider Trading & Ownership → [Webinar] A Deep Dive into Options Volatility: Skew & Relative Value (From OIC) (Ad) Free AVTX Stock Alerts $10.85 -0.64 (-5.57%) (As of 05/10/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Avalo Therapeutics (NASDAQ:AVTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.20%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$145,324.80Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$1.68 M Get AVTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Avalo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AVTX Insider Buying and Selling by Quarter Ad Stansberry ResearchGold ManiaFormer Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here. Avalo Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/26/2023Armistice Capital, LlcMajor ShareholderSell11,442$146.40$1,675,108.80 6/20/2023Caissa Capital Management Ltd.Major ShareholderBuy8$993.60$7,948.80 6/16/2023Caissa Capital Management Ltd.Major ShareholderBuy12$936.00$11,232.00 6/14/2023Caissa Capital Management Ltd.Major ShareholderBuy25$835.20$20,880.00 6/12/2023Caissa Capital Management Ltd.Major ShareholderBuy8$1,041.60$8,332.80 6/9/2023Christopher Ryan SullivanCFOBuy2$820.80$1,641.60 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 6/9/2023Garry Arthur NeilCEOBuy16$820.80$13,132.80 5/30/2023Caissa Capital Management Ltd.Major ShareholderBuy2$688.80$1,377.60 5/25/2023Caissa Capital Management Ltd.Major ShareholderBuy8$664.80$5,318.40 5/22/2023Caissa Capital Management Ltd.Major ShareholderBuy29$801.60$23,246.40 5/18/2023Caissa Capital Management Ltd.Major ShareholderBuy54$789.60$42,638.40 5/15/2023Caissa Capital Management Ltd.Major ShareholderBuy7$612.00$4,284.00 5/12/2023Caissa Capital Management Ltd.Major ShareholderBuy9$588.00$5,292.00 (Data available from 1/1/2013 forward) AVTX Insider Trading Activity - Frequently Asked Questions Who is on Avalo Therapeutics's Insider Roster? The list of insiders at Avalo Therapeutics includes Armistice Capital, Llc, Caissa Capital Management Ltd., Christopher Ryan Sullivan, Garry Arthur Neil, H Jeffrey Wilkins, and Schond L Greenway. Learn more on insiders at AVTX. What percentage of Avalo Therapeutics stock is owned by insiders? 0.20% of Avalo Therapeutics stock is owned by insiders. Learn more on AVTX's insider holdings. Which Avalo Therapeutics insiders have been buying company stock? The following insiders have purchased AVTX shares in the last 24 months: Caissa Capital Management Ltd. ($353,508.00), Christopher Ryan Sullivan ($1,641.60), and Garry Arthur Neil ($21,619.20). How much insider buying is happening at Avalo Therapeutics? Insiders have purchased a total of 535 AVTX shares in the last 24 months for a total of $376,768.80 bought. Which Avalo Therapeutics insiders have been selling company stock? The following insider sold AVTX shares in the last 24 months: Armistice Capital, Llc ($1,675,108.80). How much insider selling is happening at Avalo Therapeutics? Insiders have sold a total of 11,442 Avalo Therapeutics shares in the last 24 months for a total of $1,675,108.80 sold. More Insider Trading Tools from MarketBeat Related Companies: VINC Insider Ownership ORGS Insider Ownership INDP Insider Ownership GLTO Insider Ownership NERV Insider Ownership VBIV Insider Ownership COCP Insider Ownership KALA Insider Ownership BIVI Insider Ownership AYTU Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year This page (NASDAQ:AVTX) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsCollapse of the Petrodollar Colonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe Exchange[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
